Dihydroceramide desaturase and dihydrosphingolipids: Debutant players in the sphingolipid arena

Progress in Lipid Research

Volumn 51, Issue 2, 2012, Pages 82-94

  Fabrias, Gemma ^a   Muñoz Olaya, Jose ^a   Cingolani, Francesca ^a   Signorelli, Paola ^b   Casas, Josefina ^a   Gagliostro, Vincenzo ^b   Ghidoni, Riccardo ^b  

^a INSTITUTE OF ADVANCED CHEMISTRY OF CATALONIA IQAC CSIC   (Spain)

^b San Paolo Medical School   (Italy)

Author keywords

Apoptosis; Autophagy; Cancer; Drug; Inhibitor; Redox

Indexed keywords

ANTINEOPLASTIC AGENT; CELECOXIB; CURCUMIN; DIHYDROCERAMIDE DESATURASE; DIHYDROCERAMIDE DESATURASE 1; DIHYDROSPHINGOLIPID; DRONABINOL; FENRETINIDE; GAMMA TOCOPHEROL; GAMMA TOCOTRIENOL; OXYGENASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RESVERATROL; SMAD2 PROTEIN; SMAD3 PROTEIN; SPHINGOLIPID; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE KINASE 1; UNCLASSIFIED DRUG; XM 462;

ALZHEIMER DISEASE; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; AUTOPHAGY; BYSTANDER EFFECT; CELL CYCLE ARREST; CHEMISTRY; CRYPTOREGIOCHEMISTRY; DEGENERATIVE SPERMATOCYTE 1 GENE; DRUG CYTOTOXICITY; DRUG STRUCTURE; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; FATTY ACID DESATURATION; GENE; GLIOBLASTOMA; GROWTH INHIBITION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; LEUKEMIA; LIPID METABOLISM; LYMPHOMA; MYRISTYLATION; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARY CANCER; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; REVIEW; STEREOCHEMISTRY; TUMOR;

ANIMALS; APOPTOSIS; CERAMIDES; ENZYME INHIBITORS; HUMANS; NADP; OXIDOREDUCTASES; SPHINGOLIPIDS; SUBSTRATE SPECIFICITY;

SPHINGOIDEA;

EID: 84855791606     PISSN: 01637827     EISSN: 18732194     Source Type: Journal    
DOI: 10.1016/j.plipres.2011.12.002     Document Type: Review

References (138)

1. R.O. Brady, and G.J. Koval The enzymatic synthesis of sphingosine J Biol Chem 233 1958 26 31
2. W. Stoffel, G. Assmann, and K. Bister Stereospecificities in the introduction of the 4t-double bond into sphinganine yielding 4t-sphingenine (sphingosine) Hoppe Seylers Z Physiol Chem 352 1971 1531 1544
3. W. Stoffel, and K. Bister Stereospecificities in the metabolic reactions of the four isomeric sphinganines (dihydrosphingosines) in rat liver Hoppe Seylers Z Physiol Chem 354 1973 169 181
4. M.W. Crossman, and C.B. Hirschberg Biosynthesis of 4D-hydroxysphinganine by the rat. En bloc incorporation of the sphinganine carbon backbone Biochim Biophys Acta 795 1984 411 416 (Pubitemid 14006629)
5. M.W. Crossman, and C.B. Hirschberg Biosynthesis of phytosphingosine by the rat J Biol Chem 252 1977 5815 5819 (Pubitemid 8177758)
6. D.E. Ong, and R.N. Brady In vivo studies on the introduction of the 4-t-double bond of the sphingenine moiety of rat brain ceramides J Biol Chem 248 1973 3884 3888
7. A.H. Merrill Jr., and E. Wang Biosynthesis of long-chain (sphingoid) bases from serine by LM cells. Evidence for introduction of the 4-trans-double bond after de novo biosynthesis of N-acylsphinganine(s) J Biol Chem 261 1986 3764 3769 (Pubitemid 17200678)
8. Z. Mao, W. Sun, R. Xu, S. Novgorodov, Z.M. Szulc, and J. Bielawski Alkaline ceramidase 2 (ACER2) and its product dihydrosphingosine mediate the cytotoxicity of 4-HPR in tumor cells J Biol Chem 285 2010 29078 29090
9. W. Hu, R. Xu, W. Sun, Z.M. Szulc, J. Bielawski, and L.M. Obeid Alkaline ceramidase 3 (ACER3) hydrolyzes unsaturated long-chain ceramides, and its down-regulation inhibits both cell proliferation and apoptosis J Biol Chem 285 2010 7964 7976
10. L. Geeraert, G.P. Mannaerts, and P.P. van Veldhoven Conversion of dihydroceramide into ceramide: involvement of a desaturase Biochem J 327 1997 125 132 (Pubitemid 27455469)
11. C. Michel, G. van Echten-Deckert, J. Rother, K. Sandhoff, E. Wang, and A.H. Merrill Jr. Characterization of ceramide synthesis. A dihydroceramide desaturase introduces the 4,5-trans-double bond of sphingosine at the level of dihydroceramide J Biol Chem 272 1997 22432 22437 (Pubitemid 27386051)
12. H. Schulze, C. Michel, and G. van Echten-Deckert Dihydroceramide desaturase Methods Enzymol 311 2000 22 30 (Pubitemid 29512747)
13. C. Michel, and G. van Echten-Deckert Conversion of dihydroceramide to ceramide occurs at the cytosolic face of the endoplasmic reticulum FEBS Lett 416 1997 153 155 (Pubitemid 27462776)
14. A. Enomoto, F. Omae, M. Miyazaki, Y. Kozutsumi, T. Yubisui, and A. Suzuki Dihydroceramide:sphinganine C-4 hydroxylation requires DES2 hydroxylase and the membrane form of cytochrome b5 Biochem J 397 2006 289 295 (Pubitemid 44076898)
15. K. Endo, T. Akiyama, S. Kobayashi, and M. Okada Degenerative spermatocyte, a novel gene encoding a transmembrane protein required for the initiation of meiosis in Drosophila spermatogenesis Mol Gen Genet 253 1996 157 165 (Pubitemid 26420000)
16. K. Endo, Y. Matsuda, and S. Kobayashi Mdes, a mouse homolog of the Drosophila degenerative spermatocyte gene is expressed during mouse spermatogenesis Dev Growth Differ 39 1997 399 403 (Pubitemid 27251827)
17. D.L. Cadena, R.C. Kurten, and G.N. Gill The product of the MLD gene is a member of the membrane fatty acid desaturase family: overexpression of MLD inhibits EGF receptor biosynthesis Biochemistry 36 1997 6960 6967 (Pubitemid 27258108)
18. P. Ternes, S. Franke, U. Zahringer, P. Sperling, and E. Heinz Identification and characterization of a sphingolipid delta4-desaturase family J Biol Chem 277 2002 25512 25518 (Pubitemid 34951866)
19. F. Omae, M. Miyazaki, A. Enomoto, and A. Suzuki Identification of an essential sequence for dihydroceramide C-4 hydroxylase activity of mouse DES2 FEBS Lett 576 2004 63 67 (Pubitemid 39330458)
20. F. Omae, M. Miyazaki, A. Enomoto, M. Suzuki, Y. Suzuki, and A. Suzuki DES2 protein responsible for phytoceramide biosynthesis in the mouse small intestine Biochem J 379 2004 687 695 (Pubitemid 38703653)
21. Y. Mizutani, A. Kihara, and Y. Igarashi Identification of the human sphingolipid C4-hydroxylase, hDES2, and its up-regulation during keratinocyte differentiation FEBS Lett 563 2004 93 97 (Pubitemid 38471580)
22. J. Shanklin, and E.B. Cahoon Desaturation and related modification of fatty acids Annu Rev Plant Physiol Plant Mol Biol 49 1998 611 641
23. E. Beauchamp, D. Goenaga, J. Le Bloc'h, D. Catheline, P. Legrand, and V. Rioux Myristic acid increases the activity of dihydroceramide Delta4-desaturase 1 through its N-terminal myristoylation Biochimie 89 2007 153 161
24. E. Beauchamp, X. Tekpli, G. Marteil, D. Lagadic-Gossmann, P. Legrand, and V. Rioux N-Myristoylation targets dihydroceramide [Delta]4-desaturase 1 to mitochondria: partial involvement in the apoptotic effect of myristic acid Biochimie 91 2009 1411 1419
25. T.A. Farazi, G. Waksman, and J.I. Gordon The biology and enzymology of protein N-myristoylation J Biol Chem 276 2001 39501 39504
26. 4-desaturase: defining the role of sphingosine and sphingosine-1-phosphate in Arabidopsis thaliana Plant Physiol 149 2008 487 498
27. M. Rahmaniyan, R.W. Curley Jr., L.M. Obeid, Y.A. Hannun, and J.M. Kraveka Identification of Dihydroceramide Desaturase as a Direct in vitro target for Fenretinide J Biol Chem 286 2011 24754 24764
28. G. Triola, G. Fabrias, and A. Llebaria Synthesis of a cyclopropene analogue of ceramide, a potent inhibitor of dihydroceramide desaturase Angew Chem Int Ed Engl 40 2001 1960 1962 (Pubitemid 32525109)
29. K. Raith, J. Darius, and R.H. Neubert Ceramide analysis utilizing gas chromatography-mass spectrometry J Chromatogr A 876 2000 229 233 (Pubitemid 30211566)
30. J.M. Munoz-Olaya, X. Matabosch, C. Bedia, M. Egido-Gabas, J. Casas, and A. Llebaria Synthesis and biological activity of a novel inhibitor of dihydroceramide desaturase Chem Med Chem 3 2008 946 953
31. C. Beckmann, J. Rattke, P. Sperling, E. Heinz, and W. Boland Stereochemistry of a bifunctional dihydroceramide delta 4-desaturase/hydroxylase from Candida albicans; a key enzyme of sphingolipid metabolism Org Biomol Chem 1 2003 2448 2454
32. C.K. Savile, G. Fabrias, and P.H. Buist Dihydroceramide D4 desaturase initiates substrate oxidation at C-4 J Am Chem Soc 123 2001 4382 4385 (Pubitemid 32923364)
33. T. Mikami, M. Kashiwagi, K. Tsuchihashi, T. Akino, and S. Gasa Substrate specificity and some other enzymatic properties of dihydroceramide desaturase (ceramide synthase) in fetal rat skin J Biochem (Tokyo) 123 1998 906 911 (Pubitemid 28226988)
34. T. De Luca, E. Bosneaga, D.M. Morre, and D.J. Morre Downstream targets of altered sphingolipid metabolism in response to inhibition of ENOX2 by phenoxodiol Biofactors 34 2009 253 260
35. T. De Luca, D.M. Morre, and D.J. Morre Reciprocal relationship between cytosolic NADH and ENOX2 inhibition triggers sphingolipid-induced apoptosis in HeLa cells J Cell Biochem 110 2010 1504 1511
36. S.F. Martin, C. Gomez-Diaz, R.I. Bello, P. Navas, and J.M. Villalba Inhibition of neutral Mg(2+)-dependent sphingomyelinase by ubiquinol-mediated plasma membrane electron transport Protoplasma 221 2003 109 116 (Pubitemid 36658590)
37. P. Navas, D.M. Fernandez-Ayala, S.F. Martin, G. Lopez-Lluch, R. De Caboa, and J.C. Rodriguez-Aguilera Ceramide-dependent caspase 3 activation is prevented by coenzyme Q from plasma membrane in serum-deprived cells Free Radic Res 36 2002 369 374 (Pubitemid 35154084)
38. M.P. Barroso, C. Gomez-Diaz, J.M. Villalba, M.I. Buron, G. Lopez-Lluch, and P. Navas Plasma membrane ubiquinone controls ceramide production and prevents cell death induced by serum withdrawal J Bioenerg Biomembr 29 1997 259 267 (Pubitemid 27371727)
39. W. Ying NAD+/NADH and NADP+/NADPH in cellular functions and cell death: regulation and biological consequences Antioxid Redox Signal 10 2008 179 206
40. J.S. Won, and I. Singh Sphingolipid signaling and redox regulation Free Radic Biol Med 40 2006 1875 1888 (Pubitemid 43728861)
41. S. Yoshimura, Y. Banno, S. Nakashima, K. Hayashi, H. Yamakawa, and M. Sawada Inhibition of neutral sphingomyelinase activation and ceramide formation by glutathione in hypoxic PC12 cell death J Neurochem 73 1999 675 683 (Pubitemid 29339841)
42. G.S. Dbaibo, M.Y. Pushkareva, R.A. Rachid, N. Alter, M.J. Smyth, and L.M. Obeid P53-dependent ceramide response to genotoxic stress J Clin Invest 102 1998 329 339 (Pubitemid 28335192)
43. Wu BX, Clarke CJ, Hannun YA. Mammalian neutral sphingomyelinases: regulation and roles in cell signaling responses. Neuromolecular Med. 2010.
44. B. Liu, and Y.A. Hannun Inhibition of the neutral magnesium-dependent sphingomyelinase by glutathione J Biol Chem 272 1997 16281 16287 (Pubitemid 27276449)
45. B. Liu, N. Andrieu-Abadie, T. Levade, P. Zhang, L.M. Obeid, and Y.A. Hannun Glutathione regulation of neutral sphingomyelinase in tumor necrosis factor-alpha-induced cell death J Biol Chem 273 1998 11313 11320 (Pubitemid 28204985)
46. J. Idkowiak-Baldys, A. Apraiz, L. Li, M. Rahmaniyan, C.J. Clarke, and J.M. Kraveka Dihydroceramide desaturase activity is modulated by oxidative stress Biochem J 427 2010 265 274
47. P. Signorelli, J.M. Munoz-Olaya, V. Gagliostro, J. Casas, R. Ghidoni, and G. Fabrias Dihydroceramide intracellular increase in response to resveratrol treatment mediates autophagy in gastric cancer cells Cancer Lett 282 2009 238 243
48. I. Sultan, C.E. Senkal, S. Ponnusamy, J. Bielawski, Z.M. Szulc, and A. Bielawska Regulation of the sphingosine recycling pathway for ceramide generation by oxidative stress, and its role in controlling c-Myc/Max function Biochem J 393 2006 513 521 (Pubitemid 43099090)
49. S. Ponnusamy, M. Meyers-Needham, C.E. Senkal, S.A. Saddoughi, D. Sentelle, and S.P. Selvam Sphingolipids and cancer: ceramide and sphingosine-1-phosphate in the regulation of cell death and drug resistance Future Oncol 6 2010 1603 1624
50. N.A. Denisova, I. Cantuti-Castelvetri, W.N. Hassan, K.E. Paulson, and J.A. Joseph Role of membrane lipids in regulation of vulnerability to oxidative stress in PC12 cells: implication for aging Free Radic Biol Med 30 2001 671 678 (Pubitemid 32280793)
51. B.P. Tu, and J.S. Weissman Oxidative protein folding in eukaryotes: mechanisms and consequences J Cell Biol 164 2004 341 346 (Pubitemid 38174761)
52. M. Keller, D. Lidington, L. Vogel, B.F. Peter, H.Y. Sohn, and P.J. Pagano Sphingosine kinase functionally links elevated transmural pressure and increased reactive oxygen species formation in resistance arteries FASEB J 20 2006 702 704 (Pubitemid 46671187)
53. X. Li, K.A. Becker, and Y. Zhang Ceramide in redox signaling and cardiovascular diseases Cell Physiol Biochem 26 2010 41 48
54. D.X. Zhang, A.P. Zou, and P.L. Li Ceramide-induced activation of NADPH oxidase and endothelial dysfunction in small coronary arteries Am J Physiol Heart Circ Physiol 284 2003 H605 H612
55. R. Reinehr, S. Becker, A. Eberle, S. Grether-Beck, and D. Haussinger Involvement of NADPH oxidase isoforms and Src family kinases in CD95-dependent hepatocyte apoptosis J Biol Chem 280 2005 27179 27194 (Pubitemid 41040757)
56. P. Moskwa, A. Palicz, M.H. Paclet, M.C. Dagher, M. Erdos, and L. Marodi Glucocerebroside inhibits NADPH oxidase activation in cell-free system Biochim Biophys Acta 1688 2004 197 203 (Pubitemid 38438522)
57. Y. Liel, A. Rudich, O. Nagauker-Shriker, T. Yermiyahu, and R. Levy Monocyte dysfunction in patients with Gaucher disease: evidence for interference of glucocerebroside with superoxide generation [see comments] Blood 83 1994 2646 2653 (Pubitemid 24135858)
58. A.O. Brightman, J. Wang, R.K. Miu, I.L. Sun, R. Barr, and F.L. Crane A growth factor- and hormone-stimulated NADH oxidase from rat liver plasma membrane Biochim Biophys Acta 1105 1992 109 117
59. T. Arai, A.K. Bhunia, S. Chatterjee, and G.B. Bulkley Lactosylceramide stimulates human neutrophils to upregulate Mac-1, adhere to endothelium, and generate reactive oxygen metabolites in vitro Circ Res 82 1998 540 547 (Pubitemid 28129024)
60. C. Garcia-Ruiz, A. Colell, R. Paris, and J.C. Fernandez-Checa Direct interaction of GD3 ganglioside with mitochondria generates reactive oxygen species followed by mitochondrial permeability transition, cytochrome c release, and caspase activation FASEB J 14 2000 847 858 (Pubitemid 30241661)
61. G.M. Strub, M. Maceyka, N.C. Hait, S. Milstien, and S. Spiegel Extracellular and intracellular actions of sphingosine-1-phosphate Adv Exp Med Biol 688 2010 141 155
62. C. Garcia-Ruiz, A. Colell, M. Mari, A. Morales, and J.C. Fernandez-Checa Direct effect of ceramide on the mitochondrial electron transport chain leads to generation of reactive oxygen species. Role of mitochondrial glutathione J Biol Chem 272 1997 11369 11377 (Pubitemid 27184141)
63. G. Triola, G. Fabrias, J. Casas, and A. Llebaria Synthesis of cyclopropene analogues of ceramide and their effect on dihydroceramide desaturase J Org Chem 68 2003 9924 9932 (Pubitemid 38017845)
64. G. Triola, G. Fabrias, M. Dragusin, L. Niederhausen, R. Broere, and A. Llebaria Specificity of the dihydroceramide desaturase inhibitor GT11 in primary cultured cerebellar neurons Mol Pharmacol 66 2004 1671 1678
65. J.M. Kraveka, L. Li, Z.M. Szulc, J. Bielawski, B. Ogretmen, and Y.A. Hannun Involvement of the dihydroceramide desaturase in cell cycle progression in human neuroblastoma cells J Biol Chem 282 2007 16718 16728 (Pubitemid 47093220)
66. C. Bedia, G. Triola, J. Casas, A. Llebaria, and G. Fabrias Analogs of the dihydroceramide desaturase inhibitor GT11 modified at the amide function: synthesis and biological activities Org Biomol Chem 3 2005 3707 3712 (Pubitemid 41603768)
67. C.R. Vieira, J.M. Munoz-Olaya, J. Sot, S. Jimenez-Baranda, N. Izquierdo-Useros, and J.L. Abad Dihydrosphingomyelin Impairs HIV-1 Infection by rigidifying liquid-ordered membrane domains Chem Biol 17 2010 766 775
68. S. De Jonghe, I. Van Overmeire, S. Van Calenbergh, C. Hendrix, R. Busson, and D. De Keukeleire Synthesis of fluorinated sphinganine and dihydroceramide analogues Eur J Org Chem 2000 3177 3183
69. S. Brodesser, P. Sawatzki, and T. Kolter Bioorganic chemistry of ceramide Eur J Org Chem 2003 2021 2034
70. S. Brodesser, and T. Kolter Dihydroceramide desaturase inhibition by a cyclopropanated dihydroceramide analog in cultured keratinocytes J Lipids 2011 2011 724015
71. J.D. Fishbein, R.T. Dobrowsky, A. Bielawska, S. Garrett, and Y.A. Hannun Ceramide-mediated growth inhibition and CAPP are conserved in Saccharomyces cerevisiae J Biol Chem 268 1993 9255 9261 (Pubitemid 23145968)
72. A. Bielawska, H.M. Crane, D. Liotta, L.M. Obeid, and Y.A. Hannun Selectivity of ceramide-mediated biology. Lack of activity of erythro- dihydroceramide J Biol Chem 268 1993 26226 26232 (Pubitemid 23361691)
73. A.H.J. Merrill De novo sphingolipid biosynthesis: a necessary, but dangerous, pathway J Biol Chem 277 2002 25843 25846
74. C.G. Simon Jr., and A.R. Gear Membrane-destabilizing properties of C2-ceramide may be responsible for its ability to inhibit platelet aggregation Biochemistry 37 1998 2059 2069 (Pubitemid 28099830)
75. J. Chen, M. Nikolova-Karakashian, A.H. Merrill Jr., and E.T. Morgan Regulation of cytochrome P450 2C11 (CYP2C11) gene expression by interleukin-1, sphingomyelin hydrolysis, and ceramides in rat hepatocytes J Biol Chem 270 1995 25233 25238
76. S. El Bawab, A. Bielawska, and Y.A. Hannun Purification and characterization of a membrane-bound nonlysosomal ceramidase from rat brain J Biol Chem 274 1999 27948 27955
77. F. Scarlatti, C. Bauvy, A. Ventruti, G. Sala, F. Cluzeaud, and A. Vandewalle Ceramide-mediated macroautophagy involves inhibition of protein kinase B and up-regulation of beclin 1 J Biol Chem 279 2004 18384 18391 (Pubitemid 38623254)
78. F.G. Lu, and C.S. Wong Radiation-induced apoptosis of oligodendrocytes and its association with increased ceramide and down-regulated protein kinase B/Akt activity Int J Radiat Biol 80 2004 39 51 (Pubitemid 38365711)
79. V. Parra, V. Eisner, M. Chiong, A. Criollo, F. Moraga, and A. Garcia Changes in mitochondrial dynamics during ceramide-induced cardiomyocyte early apoptosis Cardiovasc Res 77 2007 387 397
80. M. Tong, and S.M. de la Monte Mechanisms of ceramide-mediated neurodegeneration J Alzheimers Dis 16 2009 705 714
81. J. Villena, M. Henriquez, V. Torres, F. Moraga, J. Diaz-Elizondo, and C. Arredondo Ceramide-induced formation of ROS and ATP depletion trigger necrosis in lymphoid cells Free Radic Biol Med 44 2007 1146 1160
82. W. Zheng, J. Kollmeyer, H. Symolon, A. Momin, E. Munter, and E. Wang Ceramides and other bioactive sphingolipid backbones in health and disease: lipidomic analysis, metabolism and roles in membrane structure, dynamics, signaling and autophagy Biochim Biophys Acta 1758 2006 1864 1884 (Pubitemid 44879367)
83. H. Van Overloop, S. Gijsbers, and P.P. Van Veldhoven Further characterization of mammalian ceramide kinase: substrate delivery and (stereo)specificity, tissue distribution and subcellular localization studies J Lipid Res 47 2006 268 283 (Pubitemid 43276913)
84. K. Kumagai, S. Yasuda, K. Okemoto, M. Nishijima, S. Kobayashi, and K. Hanada CERT mediates intermembrane transfer of various molecular species of ceramides J Biol Chem 280 2004 6488 6495 (Pubitemid 40341197)
85. J.P. Jaffrezou, N. Maestre, V. Demasmansat, C. Bezombes, T. Levade, and G. Laurent Positive feedback control of neutral sphingomyelinase activity by ceramide FASEB J 12 1998 999 1006 (Pubitemid 28359581)
86. B. Ogretmen, B.J. Pettus, M.J. Rossi, R. Wood, J. Usta, and Z. Szulc Biochemical mechanisms of the generation of endogenous long chain ceramide in response to exogenous short chain ceramide in the A549 human lung adenocarcinoma cell line: role for endogenous ceramide in mediating the action of exogenous ceramide J Biol Chem 277 2002 12960 12969 (Pubitemid 34952664)
87. C. Mao, and L.M. Obeid Ceramidases: regulators of cellular responses mediated by ceramide, sphingosine, and sphingosine-1-phosphate Biochim Biophys Acta 1781 2008 424 434
88. J. Stiban, D. Fistere, and M. Colombini Dihydroceramide hinders ceramide channel formation: implications on apoptosis Apoptosis 11 2006 773 780 (Pubitemid 43876846)
89. H. Wang, B.J. Maurer, Y.Y. Liu, E. Wang, J.C. Allegood, and S. Kelly N-(4-Hydroxyphenyl)retinamide increases dihydroceramide and synergizes with dimethylsphingosine to enhance cancer cell killing Mol Cancer Ther 7 2008 2967 2976
90. M. Valsecchi, M. Aureli, L. Mauri, G. Illuzzi, V. Chigorno, and A. Prinetti Sphingolipidomics of A2780 human ovarian carcinoma cells treated with synthetic retinoids J Lipid Res 51 2010 1832 1840
91. B.J. Maurer, L. Melton, C. Billups, M.C. Cabot, and C.P. Reynolds Synergistic cytotoxicity in solid tumor cell lines between N-(4-hydroxyphenyl) retinamide and modulators of ceramide metabolism J Natl Cancer Inst 92 2000 1897 1909 (Pubitemid 32036920)
92. M.C. Morales, G. Perez-Yarza, N.N. Rementeria, M.D. Boyano, A. Apraiz, and A. Gomez-Munoz 4-HPR-mediated leukemia cell cytotoxicity is triggered by ceramide-induced mitochondrial oxidative stress and is regulated downstream by Bcl-2 Free Radic Res 41 2007 591 601 (Pubitemid 46511124)
93. H. Wang, B.J. Maurer, C.P. Reynolds, and M.C. Cabot N-(4-hydroxyphenyl) retinamide elevates ceramide in neuroblastoma cell lines by coordinate activation of serine palmitoyltransferase and ceramide synthase Cancer Res 61 2001 5102 5105 (Pubitemid 32681541)
94. J.K. Kundu, and Y.J. Surh Cancer chemopreventive and therapeutic potential of resveratrol: mechanistic perspectives Cancer Lett 269 2008 243 261
95. S. Pervaiz, and A.L. Holme Resveratrol: its biologic targets and functional activity Antioxid Redox Signal 11 2009 2851 2897
96. S. Shankar, G. Singh, and R.K. Srivastava Chemoprevention by resveratrol: molecular mechanisms and therapeutic potential Front Biosci 12 2007 4839 4854
97. Z. Cakir, G. Saydam, F. Sahin, and Y. Baran The roles of bioactive sphingolipids in resveratrol-induced apoptosis in HL60: acute myeloid leukemia cells J Cancer Research Clin Oncol 137 2010 279 286
98. E. Dolfini, L. Roncoroni, E. Dogliotti, G. Sala, E. Erba, and N. Sacchi Resveratrol impairs the formation of MDA-MB-231 multicellular tumor spheroids concomitant with ceramide accumulation Cancer Lett 249 2007 143 147 (Pubitemid 46452922)
99. G. Sala, F. Minutolo, M. Macchia, N. Sacchi, and R. Ghidoni Resveratrol structure and ceramide-associated growth inhibition in prostate cancer cells Drugs Exp Clin Res 29 2003 263 269 (Pubitemid 38568633)
100. F. Scarlatti, R. Maffei, I. Beau, P. Codogno, and R. Ghidoni Role of non-canonical Beclin 1-independent autophagy in cell death induced by resveratrol in human breast cancer cells Cell Death Differ 15 2008 1318 1329 (Pubitemid 351984760)
101. K. Singletary, and J. Milner Diet, autophagy, and cancer: a review Cancer Epidemiol Biomarkers Prev 17 2008 1596 1610
102. F. Scarlatti, R. Granata, A.J. Meijer, and P. Codogno Does autophagy have a license to kill mammalian cells? Cell Death Differ 16 2009 12 20
103. K. Ohshiro, S.K. Rayala, A.K. El-Naggar, and R. Kumar Delivery of cytoplasmic proteins to autophagosomes Autophagy 4 2008 104 106
104. A. Kueck, A.W. Opipari Jr., K.A. Griffith, L. Tan, M. Choi, and J. Huang Resveratrol inhibits glucose metabolism in human ovarian cancer cells Gynecol Oncol 107 2007 450 457 (Pubitemid 350160855)
105. A.Y. Chan, V.W. Dolinsky, C.L. Soltys, B. Viollet, S. Baksh, and P.E. Light Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt J Biol Chem 283 2008 24194 24201
106. K. Venkatachalam, S. Mummidi, D.M. Cortez, S.D. Prabhu, A.J. Valente, and B. Chandrasekar Resveratrol inhibits high glucose-induced PI3K/Akt/ERK- dependent interleukin-17 expression in primary mouse cardiac fibroblasts Am J Physiol Heart Circ Physiol 294 2008 H2078 H2087
107. V.W. Dolinsky, A.Y. Chan, I. Robillard Frayne, P.E. Light, C. Des Rosiers, and J.R. Dyck Resveratrol prevents the prohypertrophic effects of oxidative stress on LKB1 Circulation 119 2009 1643 1652
108. H. Aoki, Y. Takada, S. Kondo, R. Sawaya, B.B. Aggarwal, and Y. Kondo Evidence that curcumin suppresses the growth of malignant gliomas in vitro and in vivo through induction of autophagy: role of Akt and extracellular signal-regulated kinase signaling pathways Mol Pharmacol 72 2007 29 39 (Pubitemid 46998522)
109. W. Zheng Phenretinide (4-hydroxyphenylretinamide) increases dihydroceramide and dihydrosphingolipids due to inhibition of dihydroceramide desaturase 2006 Georgia Institute of Technology Atlanta
110. S. Schiffmann, J. Sandner, R. Schmidt, K. Birod, I. Wobst, and H. Schmidt The selective COX-2-inhibitor celecoxib modulates sphingolipid synthesis J Lipid Res 50 2009 32 40
111. A. Carracedo, M. Gironella, M. Lorente, S. Garcia, M. Guzman, and G. Velasco Cannabinoids induce apoptosis of pancreatic tumor cells via endoplasmic reticulum stress-related genes Cancer Res 66 2006 6748 6755 (Pubitemid 44085633)
112. A. Carracedo, M. Lorente, A. Egia, C. Blazquez, S. Garcia, and V. Giroux The stress-regulated protein p8 mediates cannabinoid-induced apoptosis of tumor cells Cancer Cell 9 2006 301 312
113. M. Salazar, A. Carracedo, I.J. Salanueva, S. Hernandez-Tiedra, M. Lorente, and A. Egia Cannabinoid action induces autophagymediated cell death through stimulation of ER stress in human glioma cells J Clin Invest 119 2009 1359 1372
114. M. Salazar, A. Carracedo, I.J. Salanueva, S. Hernandez-Tiedra, A. Egia, and M. Lorente TRB3 links ER stress to autophagy in cannabinoid anti-tumoral action Autophagy 5 2009 1048 1049
115. Q. Jiang, X. Rao, C.Y. Kim, H. Freiser, Q. Zhang, and Z. Jiang Gamma-tocotrienol induces apoptosis and autophagy in prostate cancer cells by increasing intracellular dihydrosphingosine and dihydroceramide Int J Cancer. 2011
116. Q. Jiang, J. Wong, H. Fyrst, J.D. Saba, and B.N. Ames Γ-Tocopherol or combinations of vitamin E forms induce cell death in human prostate cancer cells by interrupting sphingolipid synthesis Proc Natl Acad Sci USA 101 2004 17825 17830 (Pubitemid 40051971)
117. D. Separovic, J. Bielawski, J.S. Pierce, S. Merchant, A.L. Tarca, and B. Ogretmen Increased tumour dihydroceramide production after Photofrin-PDT alone and improved tumour response after the combination with the ceramide analogue LCL29. Evidence from mouse squamous cell carcinomas Br J Cancer 100 2009 626 632
118. T.C. Hsieh, and J.M. Wu Resveratrol: biological and pharmaceutical properties as anticancer molecule Biofactors 36 2010 360 369
119. H. Kawashima, K. Akimoto, S. Jareonkitmongkol, N. Shirasaka, and S. Shimizu Inhibition of rat liver microsomal desaturases by curcumin and related compounds Biosci Biotechnol Biochem 60 1996 108 110
120. J.M. Deeley, T.W. Mitchell, X. Wei, J. Korth, J.R. Nealon, and S.J. Blanksby Human lens lipids differ markedly from those of commonly used experimental animals Biochim Biophys Acta 1781 2008 288 298
121. J.M. Deeley, J.A. Hankin, M.G. Friedrich, R.C. Murphy, R.J. Truscott, and T.W. Mitchell Sphingolipid distribution changes with age in the human lens J Lipid Res 51 2010 2753 2760
122. S. Bu, B. Kapanadze, T. Hsu, and M. Trojanowska Opposite effects of dihydrosphingosine 1-phosphate and sphingosine 1-phosphate on transforming growth factor-beta/Smad signaling are mediated through the PTEN/PPM1A-dependent pathway J Biol Chem 283 2008 19593 19602
123. S. Bu, M. Yamanaka, H. Pei, A. Bielawska, J. Bielawski, and Y.A. Hannun Dihydrosphingosine 1-phosphate stimulates MMP1 gene expression via activation of ERK1/2-Ets1 pathway in human fibroblasts FASEB J 20 2006 184 186 (Pubitemid 43100508)
124. M. Yamanaka, D. Shegogue, H. Pei, S. Bu, A. Bielawska, and J. Bielawski Sphingosine kinase (SPHK1) is induced by TGF-beta and mediates TIMP-1 upregulation J Biol Chem 279 2004 53994 54001 (Pubitemid 40053131)
125. S. Bu, Y. Asano, A. Bujor, K. Highland, F. Hant, and M. Trojanowska Dihydrosphingosine-1 phosphate has a potent anti-fibrotic effect in Scleroderma fibroblasts via normalization of PTEN levels Arthritis Rheum 62 2010 2117 2126
126. S.W. Park, M. Kim, S.W. Chen, V.D. D'Agati, and H.T. Lee Sphinganine-1-phosphate attenuates both hepatic and renal injury induced by hepatic ischemia and reperfusion in mice Shock 33 2010 31 42
127. S.W. Park, M. Kim, S.W. Chen, K.M. Brown, V.D. D'Agati, and H.T. Lee Sphinganine-1-phosphate protects kidney and liver after hepatic ischemia and reperfusion in mice through S1P1 receptor activation Lab Invest 90 2010 1209 1224
128. C.M. Devlin, T. Lahm, W.C. Hubbard, M. Van Demark, K.C. Wang, and X. Wu Dihydroceramide-based response to Hypoxia J Biol Chem 286 2011 38069 38078
129. C.L. Cannon, M.P. Kowalski, K.S. Stopak, and G.B. Pier Pseudomonas aeruginosa-induced apoptosis is defective in respiratory epithelial cells expressing mutant cystic fibrosis transmembrane conductance regulator Am J Respir Cell Mol Biol 29 2003 188 197 (Pubitemid 36936646)
130. T. Zaidi, M. Bajmoczi, D.E. Golan, and G.B. Pier Disruption of CFTR-dependent lipid rafts reduces bacterial levels and corneal disease in a murine model of Pseudomonas aeruginosa keratitis Invest Ophthalmol Vis Sci 49 2008 1000 1009
131. V. Teichgraber, M. Ulrich, N. Endlich, J. Riethmuller, B. Wilker, and C.C. De Oliveira-Munding Ceramide accumulation mediates inflammation, cell death and infection susceptibility in cystic fibrosis Nat Med 14 2008 382 391 (Pubitemid 351499396)
132. K.A. Becker, J. Riethmuller, Y. Zhang, and E. Gulbins The role of sphingolipids and ceramide in pulmonary inflammation in cystic fibrosis Open Respir Med J 4 2010 39 47
133. J.M. Cordy, N.M. Hooper, and A.J. Turner The involvement of lipid rafts in Alzheimer's disease Mol Membr Biol 23 2006 111 122
134. R. Vassar, D.M. Kovacs, R. Yan, and P.C. Wong The β-secretase enzyme bace in health and alzheimer's disease: regulation, cell biology, function, and therapeutic potential J Neurosci 29 2009 12787 12794
135. R.H. Unger Lipotoxic diseases Annu Rev Med 53 2002 319 336 (Pubitemid 34177884)
136. S.A. Summers Ceramides in insulin resistance and lipotoxicity Prog Lipid Res 45 2005 42 72 (Pubitemid 43170804)
137. Summers SA. Sphingolipids and insulin resistance: the five Ws. Curr Opin Lipidol. 2010.
138. W. Hu, J. Ross, T. Geng, S.E. Brice, and L.A. Cowart Differential regulation of dihydroceramide desaturase by palmitate versus monounsaturated fatty acids: implications for insulin resistance J Biol Chem 286 2011 16596 16605